MMP9 and breast cancer: Apple polyphenol phloretin complexed with ruthenium‐activated p53 to inhibit the intrinsic apoptotic process and regulate tumor invasion by downregulating the PI3K/AKT/mTOR pathway and MMP9 levels in breast cancer cells (Roy et al., 2022).